Overview

Z-Drugs for Sleep Disorders in Alzheimer's Disease

Status:
Completed
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Zolpidem and Zoplicone are efective in the treatment of sleep disorders in Alzheimer's disease (AD)
Phase:
Phase 3
Details
Lead Sponsor:
Brasilia University Hospital
Treatments:
Zolpidem